$OPNT News Article - Opiant Pharmaceuticals Initia
Post# of 14
(Total Views: 148)
Posted On: 06/01/2022 4:35:54 PM
$OPNT News Article - Opiant Pharmaceuticals Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for OPNT003, Nasal Nalmefene, for the Treatment of Opioid Overdose https://marketwirenews.com/news-releases/opia...83821.html
(0)
(0)Opnet Technologies Inc. (OPNT) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼